Si-Bone (SIBN) Short term Debt (2019 - 2022)

Si-Bone (SIBN) recorded quarterly Short term Debt of $1.5 million in Q3 2022, down 83.3% quarter-over-quarter from $8.7 million in Q1 2020.

Si-Bone (SIBN) Short term Debt (2019 - 2022) Analysis & Trends

Si-Bone's Short term Debt history runs 3 years deep, the most recent figure standing at $1.5 million for Q3 2022.

  • In Q3 2022, Short term Debt changed N/A year-over-year to $1.5 million; the TTM figure through Sep 2022 stood at $1.5 million (changed N/A YoY), while the FY2019 annual figure was $4.4 million, changed N/A from the prior year.
  • Short term Debt was $1.5 million for Q3 2022 at Si-Bone, down from $8.7 million in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $8.7 million in Q1 2020 to a low of $1.5 million in Q3 2022.
  • Historically, Short term Debt has averaged $4.8 million across 3 years, with a median of $4.4 million in 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn
10 Si-Bone 696.98 Mn 556.86 Mn 41.94 Mn

Historic Data

Download Data
DateValue
Sep 30, 2022 1.46 Mn
Mar 31, 2020 8.73 Mn
Dec 31, 2019 4.36 Mn